|This article needs additional citations for verification. (April 2011)|
|Jmol-3D images||Image 1
|Molar mass||584.66 g mol−1|
|Supplementary data page|
|n, εr, etc.|
Solid, liquid, gas
|Spectral data||UV, IR, NMR, MS|
| (what is: / ?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Bilirubin (formerly referred to as haematoidin) is the yellow breakdown product of normal haeme catabolism. Haeme is found in haemoglobin, a principal component of red blood cells. Bilirubin is excreted in bile and urine, and elevated levels may indicate certain diseases. It is responsible for the yellow color of bruises, the background straw-yellow color of urine (via its reduced breakdown product, urobilin – the more obvious but variable bright yellow colour of urine is due to thiochrome, a breakdown product of thiamine), the brown color of feces (via its conversion to stercobilin), and the yellow discoloration in jaundice.
It has also been found in plants.
Bilirubin is very similar to the pigment phycobilin used by certain algae to capture light energy, and to the pigment phytochrome used by plants to sense light. All of these contain an open chain of four pyrrolic rings.
Like these other pigments, some of the double-bonds in bilirubin isomerize when exposed to light. This is used in the phototherapy of jaundiced newborns: the E,Z-isomers of bilirubin formed upon light exposure are more soluble than the unilluminated Z,Z-isomer, as the possibility of intramolecular hydrogen bonding is removed. This allows the excretion of unconjugated bilirubin in bile.
Some textbooks and research articles show the incorrect geometric isomer of bilirubin. The naturally occurring isomer is the Z,Z-isomer.
Bilirubin is created by the activity of biliverdin reductase on biliverdin, a green tetrapyrrolic bile pigment that is also a product of heme catabolism. Bilirubin, when oxidized, reverts to become biliverdin once again. This cycle, in addition to the demonstration of the potent antioxidant activity of bilirubin, has led to the hypothesis that bilirubin's main physiologic role is as a cellular antioxidant.
Erythrocytes (red blood cells) generated in the bone marrow are disposed of in the spleen when they get old or damaged. This releases hemoglobin, which is broken down to heme as the globin parts are turned into amino acids. The heme is then turned into unconjugated bilirubin in the reticuloendothelial cells of the spleen. This unconjugated bilirubin is not soluble in water, due to intramolecular hydrogen bonding. It is then bound to albumin and sent to the liver.
The measurement of direct bilirubin depends on its reaction with diazosulfanilic acid to create azobilirubin. However, unconjugated bilirubin also reacts slowly with diazosulfanilic acid, so that the measured indirect bilirubin is an underestimate of the true unconjugated concentration.
In the liver, bilirubin is conjugated with glucuronic acid by the enzyme glucuronyltransferase, making it soluble in water. Much of it goes into the bile and thus out into the small intestine. However, 95% of the secreted bilirubin is reabsorbed by the intestines(Terminal Ileum) and reaches the liver by portal circulation and then resecreted by the liver into the small intestine. This process is known as enterohepatic circulation.
About half of the conjugated bilirubin remaining in the large intestine (about 5% of what was originally secreted) is metabolised by colonic bacteria to form urobilinogen, which may be further oxidized to urobilin and stercobilin. Urobilin, stercobilin and their degradation products give feces its brown color. However, just like bile, some of the urobilinogen is reabsorbed and 95% of what is reabsorbed is resecreted in the bile which is also part of enterohepatic circulation. A small amount of the reabsorbed urobilinogen (about 5%) is excreted in the urine following further oxidation to urobilin which gives urine its characteristic yellow color. This whole process results in only 1–20% of secreted bile being lost in the feces. The amount lost depends on the secretion rate of bile.
Although the terms direct and indirect bilirubin are used equivalently with conjugated and unconjugated bilirubin, this is not quantitatively correct, because the direct fraction includes both conjugated bilirubin and δ bilirubin (bilirubin covalently bound to albumin, which appears in serum when hepatic excretion of conjugated bilirubin is impaired in patients with hepatobiliary disease). Furthermore, direct bilirubin tends to overestimate conjugated bilirubin levels due to unconjugated bilirubin that has reacted with diazosulfanilic acid, leading to increased azobilirubin levels (and increased direct bilirubin).
Under normal circumstances, a tiny amount of urobilinogen, if any, is excreted in the urine. If the liver's function is impaired or when biliary drainage is blocked, some of the conjugated bilirubin leaks out of the hepatocytes and appears in the urine, turning it dark amber. However, in disorders involving hemolytic anemia, an increased number of red blood cells are broken down, causing an increase in the amount of unconjugated bilirubin in the blood. Because the unconjugated bilirubin is not water-soluble, one will not see an increase in bilirubin in the urine. Because there is no problem with the liver or bile systems, this excess unconjugated bilirubin will go through all of the normal processing mechanisms that occur (e.g., conjugation, excretion in bile, metabolism to urobilinogen, reabsorption) and will show up as an increase in urine urobilinogen. This difference between increased urine bilirubin and increased urine urobilinogen helps to distinguish between various disorders in those systems.
Unconjugated hyperbilirubinaemia in a new-born can lead to accumulation of bilirubin in certain brain regions (particularly the basal nuclei) with consequent irreversible damage to these areas manifesting as various neurological deficits, seizures, abnormal reflexes and eye movements. This type of neurological injury is known as kernicterus. The spectrum of clinical effect is called Bilirubin Encephalopathy. The neurotoxicity of neonatal hyperbilirubinemia manifests because the blood–brain barrier has yet to develop fully, and bilirubin can freely pass into the brain interstitium, whereas more developed individuals with increased bilirubin in the blood are protected. Aside from specific chronic medical conditions that may lead to hyperbilirubinaemia, neonates in general are at increased risk since they lack the intestinal bacteria that facilitate the breakdown and excretion of conjugated bilirubin in the feces (this is largely why the feces of a neonate are paler than those of an adult). Instead the conjugated bilirubin is converted back into the unconjugated form by the enzyme β-glucuronidase (in the gut, this enzyme is located in the brush border of the lining intestinal cells) and a large proportion is reabsorbed through the enterohepatic circulation.
Associated Health Benefits
Recent research has indicated that in the absence of liver disease, individuals with high levels of total bilirubin may experience various health benefits exceeding those with lower levels of bilirubin. Studies have found higher levels of bilirubin in elderly individuals are associated with higher functional independence. Studies have also revealed that levels of serum bilirubin are inversely related to risk of certain heart diseases.
Bilirubin is broken down by light. Tubes containing blood or (especially) serum to be used in bilirubin assays should be protected from illumination.
Bilirubin (in blood) is in one of two forms:
|Yes (bound to glucuronic acid)||Reacts quickly when dyes (diazo reagent) are added to the blood specimen to produce azobilirubin "Direct bilirubin"|
|"BU"||"Unconjugated" or "Indirect bilirubin"||No||Reacts more slowly. Still produces azobilirubin. Ethanol makes all bilirubin react promptly then calc: Indirect bilirubin = Total bilirubin – Direct bilirubin|
Total bilirubin ("TBIL") measures both BU and BC. Total and direct bilirubin levels can be measured from the blood, but indirect bilirubin is calculated from the total and direct bilirubin.
Indirect bilirubin is fat-soluble and direct bilirubin is water-soluble.
Originally the Van den Bergh reaction was used for a qualitative estimate of bilirubin.
Total bilirubin is now often measured by the 2,5-dichlorophenyldiazonium (DPD) method, and direct bilirubin is often measured by the method of Jendrassik and Grof.
The bilirubin level found in the body reflects the balance between production and excretion. Blood test results should always be interpreted using the reference range provided by the laboratory that performed the test, but typical reference ranges for adults are provided below (different reference ranges apply for newborns):
|total bilirubin||<21 ||<1.2|
Hyperbilirubinemia results from a higher-than-normal level of bilirubin in the blood.
Mild rises in bilirubin may be caused by the following:
- Hemolysis or increased breakdown of red blood cells
- Gilbert's syndrome – a genetic disorder of bilirubin metabolism that can result in mild jaundice, found in about 5% of the population
- Rotor syndrome: non-itching jaundice, with rise of bilirubin in the patient's serum, mainly of the conjugated type.
Moderate[clarification needed] rise in bilirubin may be caused by:
- Sulfonamides are contraindicated in infants less than 2 months old (exception when used with pyrimethamine in treating toxoplasmosis) as they increase unconjugated bilirubin leading to kernicterus.
Very high[clarification needed] levels of bilirubin may be caused by:
- Neonatal hyperbilirubinaemia, where the newborn's liver is not able to properly process the bilirubin causing jaundice
- Unusually large bile duct obstruction, e.g. stone in common bile duct, tumour obstructing common bile duct etc.
- Severe liver failure with cirrhosis (e.g. primary biliary cirrhosis)
- Crigler–Najjar syndrome
- Dubin–Johnson syndrome
- Choledocholithiasis (chronic or acute).
Cirrhosis may cause normal, moderately high or high levels of bilirubin, depending on exact features of the cirrhosis
To further elucidate the causes of jaundice or increased bilirubin, it is usually simpler to look at other liver function tests (especially the enzymes alanine transaminase, aspartate transaminase, gamma-glutamyl transpeptidase, alkaline phosphatase), blood film examination (hemolysis, etc.) or evidence of infective hepatitis (e.g., hepatitis A, B, C, delta, E, etc.).
Urine bilirubin may also be clinically significant. Bilirubin is not normally detectable in the urine of healthy people. If the blood level of conjugated bilirubin becomes elevated, e.g. due to liver disease, excess conjugated bilirubin is excreted in the urine, indicating a pathological process. Unconjugated bilirubin is not water-soluble and so is not excreted in the urine. Testing urine for both bilirubin and urobilinogen can help differentiate obstructive liver disease from other causes of jaundice.
- Biliary atresia
- Bilirubin diglucuronide
- Crigler–Najjar syndrome
- Gilbert's syndrome, a genetic disorder of bilirubin metabolism that can result in mild jaundice, found in about 5% of the population.
- Hy's Law
- Primary biliary cirrhosis
- Primary sclerosing cholangitis
- Pirone, Cary; Quirke, J. Martin E.; Priestap, Horacio A.; Lee, David W. (2009). "Animal Pigment Bilirubin Discovered in Plants". Journal of the American Chemical Society 131 (8): 2830. doi:10.1021/ja809065g. PMC 2880647. PMID 19206232.
- McDonagh, Antony F; Palma; Lightner; Palma, LA; Lightner DA (11 April 1980). "Blue Light and Bilirubin Excretion". Science 208 (4440): 145–151. Bibcode:1980Sci...208..145M. doi:10.1126/science.7361112. PMID 7361112.
- "Bilirubin's Chemical Formula". Retrieved 2007-08-14.
- Stocker, R; Yamamoto, Y; McDonagh, A.; Glazer, A.; Ames, B. (1987). "Bilirubin is an antioxidant of possible physiological importance". Science 235 (4792): 1043–6. doi:10.1126/science.3029864. PMID 3029864.
- Baranano, D. E.; Rao, M.; Ferris, C. D.; Snyder, S. H. (2002). "Biliverdin reductase: A major physiologic cytoprotectant". Proceedings of the National Academy of Sciences 99 (25): 16093–8. Bibcode:2002PNAS...9916093B. doi:10.1073/pnas.252626999. JSTOR 3073913. PMC 138570. PMID 12456881.
- Sedlak, T. W.; Saleh, M.; Higginson, D. S.; Paul, B. D.; Juluri, K. R.; Snyder, S. H. (2009). "Bilirubin and glutathione have complementary antioxidant and cytoprotective roles". Proceedings of the National Academy of Sciences 106 (13): 5171–6. Bibcode:2009pnas..106.5171s. doi:10.1073/pnas.0813132106. JSTOR 40455167. PMC 2664041. PMID 19286972.
- Liu, Y; Li, P; Lu, J; Xiong, W; Oger, J; Tetzlaff, W; Cynader, M (2008). "Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis". Journal of Immunology 181 (3): 1887–97. PMID 18641326.
- Kuntz, Erwin (2008). Hepatology: Textbook and Atlas. Germany: Springer. p. 38. ISBN 978-3-540-76838-8.
- Moyer, Kathryn D.; Balistreri, William F. (2011). "Liver Disease Associated with Systemic Disorders". In Kliegman, Robert M.; Stanton, Bonita F.; St. Geme, Joseph W.; Schor, Nina F.; Behrman, Richard E. Nelson Textbook of Pediatrics. Saunders. p. 1405. ISBN 978-1-4377-0755-7.
- Sedlak, T. W.; Snyder, S. H. (2004). "Bilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant Cycle". Pediatrics 113 (6): 1776–82. doi:10.1542/peds.113.6.1776. PMID 15173506.
- Kao, T. W.; Chou, C. H.; Wang, C. C.; Chou, C. C.; Hu, J.; Chen, W. L. (2012). "Associations between serum total bilirubin levels and functional dependence in the elderly". Internal Medicine Journal 42 (11): 1199–207. doi:10.1111/j.1445-5994.2011.02620.x. PMID 22032210.
- Novotný, L; Vítek, L (2003). "Inverse relationship between serum bilirubin and atherosclerosis in men: A meta-analysis of published studies". Experimental Biology and Medicine 228 (5): 568–71. PMID 12709588.
- Schwertner, Harvey A.; Vítek, Libor (2008). "Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin". Atherosclerosis 198 (1): 1–11. doi:10.1016/j.atherosclerosis.2008.01.001. PMID 18343383.
- Watson, D.; Rogers, J. A. (1961). "A study of six representative methods of plasma bilirubin analysis". Journal of Clinical Pathology 14 (3): 271–8. doi:10.1136/jcp.14.3.271. PMC 480210. PMID 13783422.
- Boris Rolinski; Küster, H; Ugele, B; Gruber, R; Horn, K (2001-10-01). "Total Bilirubin Measurement by Photometry on a Blood Gas Analyzer: Potential for Use in Neonatal Testing at the Point of Care". Clinical Chemistry 47 (10): 1845–7. PMID 11568098.
- "Harmonisation of Reference Intervals". Pathology Harmony. Retrieved 23 June 2013.[dead link]
- Golonka, Debby. "Digestive Disorders Health Center: Bilirubin". WebMD. p. 3. Archived from the original on 1 January 2010. Retrieved 2010-01-14.
- MedlinePlus Encyclopedia CHEM-20
- "Laboratory tests". Archived from the original on 13 August 2007. Retrieved 2007-08-14.
- Stricker, Reto; Eberhart, Raphael; Chevailler, Marie-Christine; Quinn, Frank A.; Bischof, Paul; Stricker, René (2006). "Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer". Clinical Chemical Laboratory Medicine 44 (7): 883–7. doi:10.1515/CCLM.2006.160. PMID 16776638.
- Sulfonamides: Bacteria and Antibacterial Drugs: Merck Manual Professional
- Merck Manual Jaundice Last full review/revision July 2009 by Steven K. Herrine
- SI Units for Clinical Data; http://www.unc.edu/~rowlett/units/scales/clinical_data.html[dead link]
- MedlinePlus Encyclopedia Bilirubin – urine
- "Urinalysis: three types of examinations". Lab Tests Online (USA). Retrieved 16 August 2013.
- Bilirubin at Lab Tests Online
- Bilirubin: analyte monograph from The Association for Clinical Biochemistry and Laboratory Medicine